Leishmaniasis in the Military

Many veterans are now returning to the United States after potential exposure to leishmaniasis.

 

Cutaneous leishmaniasis, a vector-borne parasitic disease, is a risk for persons, including military personnel, who travel to or live in areas of the tropics, subtropics, and southern Europe where the disease is endemic.

If a patient presented with a nonhealing lesion of >3 weeks' duration, had been in a known area of endemicity with sandfly exposure, and was not successfully treated with a course of broad-spectrum antibiotic therapy, the pretest probability for leishmaniasis was very high

The parasite lives and replicates within the cells of the immune system, specifically the monocytes and macrophages. By hiding away in the immune system’s cells, the very ones responsible for capturing and devouring rogue microbes and parasites, leishmania effectively avoids any immunological confrontation. Leishamniasis is very difficult to treat and can last up to three years in some patients!

Impavido has shown great improvements in military personal and civilians who contract Leishmaniasis while abroad. 

Click here to Learn more about Leishmaniasis.

 Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO 

Contact Your Doctor or the CDC to Learn More about IMPAVIDO (miltefosine)

®

Impavido is a registered trademark of Knight Therapeutics Licensed exclusively to Profounda in the USA

© 2015 Profounda, Inc. 

For Emergencies
Call 911